The Board of Directors of Hydromer, Inc. Announces the Appointment of Peter M. von Dyck as the CEO and President following the Retirement of Manfred F. Dyck
Branchburg, NJ, Sept. 13, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Hydromer, Inc. (HYDI.PK – OTC BB), the "Company" or "Hydromer", announces that the Company's Board of Directors appointed Peter M. von Dyck as Chief Executive Officer and President effective upon the retirement from those roles by Manfred F. Dyck, effective September 14, 2018.
|
|||||
Peter M. von Dyck, recently re-joined Hydromer, Inc. as the Chief Strategy and Business Development Officer in October 2017 with a rejuvenation plan for the Company, a globally renowned and trusted organization. Peter worked for the Hydromer companies for several years in the mid-1990s but was then recruited by a multi-billion-dollar pharmaceutical company where he worked in a global sales and marketing capacity before founding his own high technology companies as CEO in 1997 and 2006. During his 20-year tenure as CEO of these companies, he was voted Leading Technology Executive (2010) and awarded the prestigious Ernst & Young's Entrepreneur of the Year for Life Sciences in Florida (2000). His medical device company also was the winner of the Fastest Growing Company award (2007). With many patents to his name, he sets forth, as a respected technology pioneer, an exceptional record of developing and leading highly innovative companies, product offerings and teams.
With deep experience in the development and global commercialization of complex life science technologies, he also brings deep digital technology acumen to Hydromer as in his last role he led a company in the development and commercialization of new cloud-based enterprise software systems (SaaS) that provided powerful new innovation management platforms to large multi-national companies. A strategic planner and change management specialist, Peter, the son of Manfred F. Dyck, is a serial CEO who has built cross-functional teams around the design, development, manufacturing and global commercialization of over a dozen breakthrough technologies while also securing millions of dollars of strategic and venture capital funding.
Outgoing CEO Manfred F. Dyck will continue to leverage his tremendous grasp of innovative chemistry and polymer design and remain with the Company as Chairman of the Board and Executive Vice President of R&D, which he has been the visionary for the past four decades since and prior to the establishment of Hydromer.
Hydromer, Inc. is an innovative ISO 9001:2015 technology- focused company engaged in the business of inventing, developing, patenting, licensing, manufacturing and selling hydrophilic polymer based products for commercial markets including Medical Device, Pharmaceutical, Biotechnology, Industrial Plastics and Cosmetic and Personal Care. Hydromer also provides highly specialized medical coating services to industry through its FDA registered and ISO 13485:2003 certified Biosearch Medical Products subsidiary.
For the latest information about Hydromer, Inc. and its products, please visit our web site at http://www.hydromer.com.
Attachment
Robert Y Lee 9087225000 r.lee@hydromer.com
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
